Pacific Biosciences targets clinical growth and $40M in savings with HiFi sequencing push

Pacific Biosciences is targeting clinical-market growth and $40 million in cost savings through its HiFi sequencing push, according to a report on the company's plans.

Detected & updated continuously · Source: Nebula